Versant Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$64.2K Sell
925
-33
-3% -$1.97K 0.01% 1229
2026
Q2
$42.7K Buy
958
+758
+379% +$35.9K ﹤0.01% 1471
2026
Q1
$10.3K Buy
200
+84
+72% +$5.88K ﹤0.01% 2130
2025
Q4
$10.7K Sell
116
-153
-57% -$14.6K ﹤0.01% 1962
2025
Q3
$20K Buy
269
+266
+8,867% +$26.9K ﹤0.01% 1579
2025
Q2
$389 Sell
3
-18
-86% -$2.61K ﹤0.01% 2565
2025
Q1
$3.34K Buy
21
+5
+31% +$905 ﹤0.01% 2175
2024
Q4
$2.97K Hold
16
– – ﹤0.01% 1961
2024
Q3
$3.38K Buy
16
+11
+220% +$1.91K ﹤0.01% 1410
2024
Q2
$669 Hold
5
– – ﹤0.01% 1737
2024
Q1
$1.07K Buy
5
+1
+25% +$196 ﹤0.01% 1520
2023
Q4
$814 Buy
+4
New +$648 ﹤0.01% 1570
2023
Q3
– Sell
-5
Closed -$1.62K – 1993
2023
Q2
$1.62K Buy
+5
New +$1.43K ﹤0.01% 1449

Other funds holding INSP

Versant Capital Management's INSP Position: Q3 2026 in Review

Versant Capital Management reduced its Inspire Medical Systems (INSP) stake by 3.4% in Q3 2026, selling an estimated $1.97K and leaving 925 shares worth $64.2K. The position accounts for 0.01% of the portfolio, ranked #1229.

Versant Capital Management first reported a position in INSP in Q2 2023 and has held it in 13 quarters since. 227 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • Versant Capital Management held 925 shares of Inspire Medical Systems worth $64.2K as of Q3 2026.
  • Versant Capital Management sold 33 Inspire Medical Systems shares in Q3 2026, an estimated $1.97K.
  • Inspire Medical Systems made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #1229 holding.
  • Versant Capital Management first reported a position in Inspire Medical Systems in Q2 2023 and has held it in 13 quarters since.
  • 227 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.